M. Limbert

993 citations

43 papers · 832 indexed · h-index 18

Impact in

Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
- Microbial Natural Products and Biosynthesis

Papers in ⓘ

Molecular Medicine 20
- Antibiotic Resistance in Bacteria 20
Pharmacology 32
- Antibiotics Pharmacokinetics and Efficacy 27
- Microbial Natural Products and Biosynthesis 5

Co-authors: Gerhard Seibert (28 shared papers)N. Klesel (24 shared papers)E. Schrinner (23 shared papers)Irvin Winkler (10 shared papers)A. Markus (11 shared papers)K. Seeger (4 shared papers)U. Hadding (5 shared papers)D Bitter-Suermann (5 shared papers)
Journals: The Journal of Antibiotics (16 papers)Journal of Antimicrobial Chemotherapy (5 papers)Infection (4 papers)Tetrahedron (3 papers)The Journal of Immunology (3 papers)
Partner nations: Germany France India

In The Last Decade

M. Limbert

41 papers receiving 704 citations

Peers

Countries citing papers authored by M. Limbert

Since Specialization

Citations

This map shows the geographic impact of M. Limbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Limbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Limbert more than expected).

Fields of papers citing papers by M. Limbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Limbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Limbert. The network helps show where M. Limbert may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Limbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Limbert Line = papers co-authored together M. Limbert links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mersacidin, a new antibiotic from Bacillus In vitro and in vivo antibacterial activity. The Journal of Antibiotics ·Sukumar Chatterjee, DIPAK KUMAR CHATTERJEE, Rajendrakumar H. Jani, J. BLUMBACH, B. N. GANGULI, N. Klesel, M. Limbert, Gerhard Seibert	1992	110
2	Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin Antimicrobial Agents and Chemotherapy ·M. Limbert, D. ISERT, N. Klesel, A. Markus, K. Seeger, Gerhard Seibert, E. Schrinner	1991	96
3	Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues European Journal of Clinical Microbiology & Infectious Diseases ·Gerhard Seibert, M. Limbert, N. Klesel	1983	46
4	Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro and in vivo) Journal of Antimicrobial Chemotherapy ·E. Schrinner, M. Limbert, L. Pénasse, A Lutz	1980	43
5	The antibacterial activity in vitro and β-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides Infection ·Gerhard Seibert, M. Limbert, Irvin Winkler, Thomas Dick	1983	43
6	Ability of the T cell‐replacing polyanion dextran sulfate to trigger the alternate pathway of complement activation European Journal of Immunology ·U. Hadding, M. P. Dierich, Wolfgang König, M. Limbert, H. U. Schorlemmer, D Bitter-Suermann	1973	34
7	ChemInform Abstract: HR 810, a New Parenteral Cephalosporin with a Broad Antibacterial Spectrum. Chemischer Informationsdienst ·Gerhard Seibert, N. KIESEL, M. Limbert, E. Schrinner, K. Seeger, Irvin Winkler, Rudolf Lattrell, J. BLUMBACH, W. DUERCKHEIMER, Klaus Fleischmann, R. G. H. KIRRSTETTER, BURKHARD MENCKE, Barry C. Ross, K. Scheunemann, Wilfried Schwab, Manfred Wieduwilt	1983	33
8	Cefodizime, an aminothiazolyl cephalosporin. IV. Influence on the immune system. The Journal of Antibiotics ·M. Limbert, Robert Bartlett, Gerhard Dickneite, N. Klesel, H. U. Schorlemmer, Gerhard Seibert, Irvin Winkler, E. Schrinner	1984	29
9	DNP-Antigens Activate the Alternate Pathway of the Complement System The Journal of Immunology ·Wolfgang König, D Bitter-Suermann, Manfred Dierich, M. Limbert, Hans-Ulrich Schorlemmer, U. Hadding	1974	27
10	Activation by Some T-Independent Antigens and B Cell Mitogens of the Alternative Pathway of the Complement System The Journal of Immunology ·D Bitter-Suermann, U. Hadding, Hans-Ulrich Schorlemmer, M. Limbert, Manfred P. Dierich, P. Dukor	1975	26
11	Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals Journal of Antimicrobial Chemotherapy ·N. Klesel, K.-H. Geweniger, P. Koletzki, D. ISERT, M. Limbert, A. Markus, G. Riess, H. Schramm, P. Iyer	1995	25
12	The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus Journal of Antimicrobial Chemotherapy ·Gerhard Seibert, D. ISERT, N. Klesel, M. Limbert, A. Markus, E. Schrinner	1992	25
13	Structures of some moenomycin antibiotics - inhibitors of peptidoglycan biosynthesis Tetrahedron ·Jürgen Scherkenbeck, Aranka Hiltmann, Kurt Hobert, Wassja Bankova, Torsten Siegels, Manfred Kaiser, D. Müller, H. J. Veith, Hans‐Wolfram Fehlhaber, Gerhard Seiberg, Astrid Markus, M. Limbert, Gerhard Huber, Dirk Böttger, Andreas M. Stark, Shuji Takahashi, Yveline van Heijenoort, Jean van Heijenoort, Peter Welzel	1993	24
14	The cooperation of cefotaxime and desacetyl-cefotaxime with respect to antibacterial activity and β-lactamase stability Infection ·M. Limbert, Gerhard Seibert, E. Schrinner	1982	22
15	Cefodizime, an aminothiazolylcephalosporin. II. Comparative studies on the pharmacokinetic behavior in laboratory animals. The Journal of Antibiotics ·N. Klesel, M. Limbert, K. Seeger, Gerhard Seibert, Irvin Winkler, E. Schrinner	1984	21
16	Cefodizime, an aminothiazolyl cephalosporin. III. Therapeutic activity against experimentally induced pneumonia in mice. The Journal of Antibiotics ·N. Klesel, M. Limbert, Gerhard Seibert, Irvin Winkler, E. Schrinner	1984	21
17	Moenomycin A: reactions at the lipid part. New structure-activity relations Tetrahedron ·Susanne Marzian, M. E. Happel, Ulrich Wagner, D. Müller, Peter Welzel, Hans‐Wolfram Fehlhaber, Andreas M. Stark, Hans‐Jürgen Schütz, Astrid Markus, M. Limbert, Yveline van Heijenoort, Jean van Heijenoort	1994	21
18	Cefodizime, an aminothiazolylcephalosporin. I. In vitro activity. The Journal of Antibiotics ·M. Limbert, N. Klesel, K. Seeger, Gerhard Seibert, Irvin Winkler, E. Schrinner	1984	21
19	Factor D in the alternative pathway of complement activation: Purification, physicochemical characterization and functional role Immunochemistry ·M. P. Dierich, U. Hadding, Wolfgang König, M. Limbert, H. U. Schorlemmer, D Bitter-Suermann	1974	17
20	Cefodizime, an aminothiazolylcephalosporin. V. Synthesis and structure-activity relationships in the cefodizime series. The Journal of Antibiotics ·J. BLUMBACH, Walter Dürckheimer, Eberhard Ehlers, Klaus Fleischmann, N. Klesel, M. Limbert, BURKHARD MENCKE, J. Reden, Karl Heinz Scheunemann, E. Schrinner, Gerhard Seibert, Manfred Wieduwilt, Manfred Worm	1987	17

About M. Limbert

M. Limbert is a scholar working on Molecular Medicine, Pharmacology, Applied Microbiology and Biotechnology, Microbiology and Clinical Biochemistry, having authored 43 papers that have together received 832 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (27 papers), Antibiotic Resistance in Bacteria (20 papers), Phenothiazines and Benzothiazines Synthesis and Activities (7 papers), Microbial Natural Products and Biosynthesis (5 papers), Cancer therapeutics and mechanisms (4 papers), Complement system in diseases (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). The work is most often cited by research in Molecular Medicine (298 citations), Pharmacology (464 citations), Microbiology (99 citations), Clinical Biochemistry (79 citations) and Applied Microbiology and Biotechnology (14 citations). M. Limbert has collaborated with scholars based in Germany, France and India. Frequent co-authors include Gerhard Seibert, N. Klesel, E. Schrinner, Irvin Winkler, A. Markus, K. Seeger, U. Hadding, D Bitter-Suermann, J. BLUMBACH and B. N. GANGULI. Their work appears in journals such as The Journal of Antibiotics, Journal of Antimicrobial Chemotherapy, Infection, Tetrahedron and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact